We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$262M
AUM Growth
-$17.6M
Cap. Flow
-$41.4M
Cap. Flow %
-15.8%
Top 10 Hldgs %
58.42%
Holding
182
New
46
Increased
31
Reduced
25
Closed
52

Sector Composition

Rank Sector Weight
1 Healthcare 7.43%
2 Communication Services 2.9%
3 Consumer Discretionary 1.78%
4 Technology 1.37%
5 Utilities 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXPI icon
51
NXP Semiconductors
NXPI
$65.4B
$726K 0.28%
6,200
+200
+3% +$23.1K
CCC
52
DELISTED
Calgon Carbon Corp
CCC
$703K 0.27%
+33,000
New +$709K
CVS icon
53
CALL
CVS Health
CVS
$140B
$696K 0.27%
9,600
CVS icon
54
PUT
CVS Health
CVS
$140B
$696K 0.27%
9,600
PVH icon
55
PVH
PVH
$4.01B
$686K 0.26%
+5,000
New +$653K
TRCO
56
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$680K 0.26%
16,001
+1,000
+7% +$41.2K
GM icon
57
PUT
General Motors
GM
$81.7B
$615K 0.23%
15,000
ABUS icon
58
Arbutus Biopharma
ABUS
$871M
$603K 0.23%
119,497
+9,497
+9% +$55.7K
AAAP
59
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$587K 0.22%
+7,192
New +$558K
HSNI
60
DELISTED
HSN, Inc.
HSNI
$569K 0.22%
14,100
+100
+0.7% +$3.95K
VIRX
61
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$565K 0.22%
4,378
-205
-4% -$19.2K
FATE icon
62
Fate Therapeutics
FATE
$270M
$557K 0.21%
91,123
-68,877
-43% -$307K
SCMP
63
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$538K 0.21%
+30,000
New +$369K
NXTM
64
DELISTED
NxStage Medical Inc.
NXTM
$533K 0.2%
22,000
-8,000
-27% -$211K
XCRA
65
DELISTED
Xcerra Corporation
XCRA
$520K 0.2%
53,100
+6,000
+13% +$59.2K
COLB icon
66
Columbia Banking Systems
COLB
$8.84B
$515K 0.2%
+11,861
New +$518K
WMT icon
67
PUT
Walmart Inc
WMT
$900B
$494K 0.19%
15,000
CAVM
68
DELISTED
Cavium, Inc.
CAVM
$419K 0.16%
+5,000
New +$387K
EWZ icon
69
PUT
iShares MSCI Brazil ETF
EWZ
$9.13B
$404K 0.15%
10,000
XLRN
70
DELISTED
Acceleron Pharma
XLRN
$403K 0.15%
9,500
-16,110
-63% -$604K
STML
71
DELISTED
Stemline Therapeutics, Inc.
STML
$390K 0.15%
25,000
+6,500
+35% +$86.9K
ACHN
72
DELISTED
Achillion Pharmaceuticals
ACHN
$389K 0.15%
+135,000
New +$490K
DB icon
73
CALL
Deutsche Bank
DB
$67.6B
$362K 0.14%
19,000
DB icon
74
PUT
Deutsche Bank
DB
$67.6B
$362K 0.14%
19,000
DNR
75
PUT
DELISTED
Denbury Resources, Inc.
DNR
$354K 0.14%
+160,000
New +$252K

Similar funds

Telemetry Investments's Q4 2017 Portfolio in Review

As of Q4 2017, Telemetry Investments held 182 positions worth $262M, down 6.3% from $280M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Telemetry Investments withdrew a net $41.4M in Q4 2017, closing 52 positions and reducing 25 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $3.07M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, down from 7.9% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Telemetry Investments opened a new position in Buffalo Wild Wings, Inc. worth $2.28M.

  • Telemetry Investments's largest Q4 2017 buy was Buffalo Wild Wings, Inc.: 14,605 shares worth $2.28M.
  • Telemetry Investments added most to Time Warner Inc in Q4 2017, an estimated $2.16M increase.
  • Telemetry Investments's biggest Q4 2017 reduction was Acceleron Pharma, cutting an estimated $604K.
  • Telemetry Investments fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $3.07M.
  • Telemetry Investments's ten largest holdings make up 58% of its $262M portfolio in Q4 2017.
  • Telemetry Investments opened 46 new positions and closed 52 in Q4 2017.
  • Telemetry Investments's portfolio value fell 6.3% quarter-over-quarter to $262M.

Based on Telemetry Investments's 13F filing for Q4 2017, filed 14 Feb 2018.